Deutsche Bank AG set a €22.00 ($25.58) price target on Rhön-Klinikum Aktiengesellschaft (ETR:RHK) in a research note issued to investors on Monday. The firm currently has a neutral rating on the stock.

Several other research analysts have also recently issued reports on RHK. S&P Global set a €25.00 ($29.07) price objective on Rhön-Klinikum Aktiengesellschaft and gave the stock a sell rating in a research report on Friday. Berenberg Bank set a €29.15 ($33.90) target price on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a report on Monday. Baader Bank set a €24.00 ($27.91) target price on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a report on Friday. Independent Research GmbH set a €32.00 ($37.21) target price on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a report on Monday. Finally, Warburg Research set a €26.30 ($30.58) target price on Rhön-Klinikum Aktiengesellschaft and gave the company a neutral rating in a report on Monday. Four equities research analysts have rated the stock with a sell rating and six have assigned a hold rating to the company’s stock. The stock currently has an average rating of Hold and a consensus target price of €25.05 ($29.13).

Rhön-Klinikum Aktiengesellschaft (RHK) traded down €0.18 ($0.21) on Monday, hitting €30.02 ($34.91). 85,284 shares of the company were exchanged, compared to its average volume of 71,494. Rhön-Klinikum Aktiengesellschaft has a 12 month low of €22.66 ($26.35) and a 12 month high of €30.65 ($35.64).

COPYRIGHT VIOLATION NOTICE: “Rhön-Klinikum Aktiengesellschaft (RHK) Given a €22.00 Price Target at Deutsche Bank AG” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this story on another publication, it was illegally copied and reposted in violation of U.S. and international copyright and trademark legislation. The legal version of this story can be read at https://www.dailypolitical.com/2017/11/14/rhon-klinikum-aktiengesellschaft-rhk-given-a-22-00-price-target-at-deutsche-bank-ag.html.

Rhön-Klinikum Aktiengesellschaft Company Profile

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services in the areas of cardiological and coronary diseases, neurological disorders, oncology, lung diseases, and orthopedic and accident surgeries; rehabilitation services; and thoracic, pulmonary and vascular diseases, tumors, heart conditions, and nervous and skeletal system diseases.

Analyst Recommendations for Rhön-Klinikum Aktiengesellschaft (ETR:RHK)

Receive News & Ratings for Rhön-Klinikum Aktiengesellschaft Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhön-Klinikum Aktiengesellschaft and related companies with MarketBeat.com's FREE daily email newsletter.